Una revisión exploratoria sobre la implantación temprana de prótesis de pene en el tratamiento del priapismo isquémico refractario
DOI:
https://doi.org/10.48193/b85sst67Palabras clave:
Priapismo, prótesis de pene, endoscopiaResumen
Objetivo: describir el estado actual de las indicaciones, complicaciones, efectos adversos, opciones terapéuticas e inserción temprana vs. tardía en pacientes con priapismo refractario sometidos a implante de prótesis de pene.
Métodos: se realizaron búsquedas en MEDLINE (OVID), EMBASE y el Registro Cochrane Central de Ensayos Controlados (CENTRAL) desde su inicio hasta la actualidad. También se consultaron guías de práctica clínica accesibles de Norteamérica, Europa, Sudáfrica y Japón.
Resultados: la búsqueda en diversos motores de búsqueda arrojó 255 artículos, de los cuales 12 se seleccionaron tras eliminar duplicados, artículos no relacionados y estudios no realizados en humanos.
Conclusión: el uso temprano de prótesis peneanas es una opción viable en el priapismo isquémico refractario al tratamiento de primera línea, disminuyendo el riesgo de eventos adversos relacionados con implantes tardíos y brindando a los pacientes la posibilidad de preservar la función sexual y, al mismo tiempo, brindar terapia a una patología inusual con comorbilidad significativa.
Referencias
Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. American Urological Association guideline on the management of priapism. The Journal of Urology. 2003;170(4 Pt 1): 1318–1324. https://doi.org/10.1097/01.ju.0000087608.07371.ca.
Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. The Journal of Sexual Medicine. 2010;7(1 Pt 2): 476–500. https://doi.org/10.1111/j.1743-6109.2009.01625.x.
Anele UA, Le BV, Resar LMS, Burnett AL. How I treat priapism. Blood. 2015;125(23): 3551–3558. https://doi.org/10.1182/blood-2014-09-551887.
Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, et al. The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline. The Journal of Urology. 2022;208(1): 43–52. https://doi.org/10.1097/JU.0000000000002767.
Burnett AL. Pathophysiology of priapism: dysregulatory erection physiology thesis. The Journal of Urology. 2003;170(1): 26–34. https://doi.org/10.1097/01.ju.0000046303.22757.f2.
Arduini GAO, Trovó de Marqui AB. Prevalence and Characteristics of Priapism in Sickle Cell Disease. Hemoglobin. 2018;42(2): 73–77. https://doi.org/10.1080/03630269.2018.1452760.
Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease-associated priapism. The Journal of Sexual Medicine. 2012;9(1): 79–87. https://doi.org/10.1111/j.1743-6109.2011.02288.x.
Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. Journal of Pediatric Hematology/Oncology. 1999;21(6): 518–522.
Capece M, La Rocca R, Mirone V, Bivalacqua TJ, Castiglione F, Albersen M, et al. A Systematic Review on Ischemic Priapism and Immediate Implantation: Do We Need More Data? Sexual Medicine Reviews. 2019;7(3): 530–534. https://doi.org/10.1016/j.sxmr.2018.10.007.
Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nature Reviews. Urology. 2019;16(10): 573–598. https://doi.org/10.1038/s41585-019-0228-9.
Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi Y, et al. European Association of Urology guidelines on priapism. European Urology. 2014;65(2): 480–489. https://doi.org/10.1016/j.eururo.2013.11.008.
Mishra K, Loeb A, Bukavina L, Baumgarten A, Beilan J, Mendez M, et al. Management of Priapism: A Contemporary Review. Sexual Medicine Reviews. 2020;8(1): 131–139. https://doi.org/10.1016/j.sxmr.2019.01.001.
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine. 2018;169(7): 467–473. https://doi.org/10.7326/M18-0850.
Sedigh O, Rolle L, Negro CLA, Ceruti C, Timpano M, Galletto E, et al. Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. International Journal of Impotence Research. 2011;23(4): 158–164. https://doi.org/10.1038/ijir.2011.23.
Zacharakis E, De Luca F, Raheem AA, Garaffa G, Christopher N, Muneer A, et al. Early insertion of a malleable penile prosthesis in ischaemic priapism allows later upsizing of the cylinders. Scandinavian Journal of Urology. 2015;49(6): 468–471. https://doi.org/10.3109/21681805.2015.1059359.
Ralph DJ, Garaffa G, Muneer A, Freeman A, Rees R, Christopher AN, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. European Urology. 2009;56(6): 1033–1038. https://doi.org/10.1016/j.eururo.2008.09.044.
Salem EA, El Aasser O. Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. The Journal of Urology. 2010;183(6): 2300–2303. https://doi.org/10.1016/j.juro.2010.02.014.
Rees RW, Kalsi J, Minhas S, Peters J, Kell P, Ralph DJ. The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU international. 2002;90(9): 893–897. https://doi.org/10.1046/j.1464-410x.2002.03058.x.
Zacharakis E, Garaffa G, Raheem AA, Christopher AN, Muneer A, Ralph DJ. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU international. 2014;114(4): 576–581. https://doi.org/10.1111/bju.12686.
Durazi MH, Jalal AA. Penile prosthesis implantation for treatment of postpriapism erectile dysfunction. Urology Journal. 2008;5(2): 115–119.
Mireku-Boateng A, Jackson AG. Penile prosthesis in the management of priapism. Urologia Internationalis. 1989;44(4): 247–248. https://doi.org/10.1159/000281515.
Tausch TJ, Zhao LC, Morey AF, Siegel JA, Belsante MJ, Seideman CA, et al. Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism. The Journal of Sexual Medicine. 2015;12(3): 824–826. https://doi.org/10.1111/jsm.12803.
Upadhyay J, Shekarriz B, Dhabuwala CB. Penile implant for intractable priapism associated with sickle cell disease. Urology. 1998;51(4): 638–639. https://doi.org/10.1016/s0090-4295(97)00704-8.
Bella A, Wang R, Shamloul R, Zappavigna C, Ahmed M, Sadeghi-Nejad H. 1859 3-piece inflatable penile prosthesis insertion post T-shunt for priapism with dilation/corporal snake maneuver and comparison to post al-ghorab shunt ipp outcomes. The Journal of Urology. 2012; https://doi.org/10.1016/j.juro.2012.02.1971.
Monga M, Broderick GA, Hellstrom WJ. Priapism in sickle cell disease: the case for early implantation of the penile prosthesis. European Urology. 1996;30(1): 54–59. https://doi.org/10.1159/000474145.
Olujohungbe A, Burnett AL. How I manage priapism due to sickle cell disease. British Journal of Haematology. 2013;160(6): 754–765. https://doi.org/10.1111/bjh.12199.
Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. The Journal of Urology. 1994;151(4): 878–879. https://doi.org/10.1016/s0022-5347(17)35111-x.
Zacharakis E, Raheem AA, Freeman A, Skolarikos A, Garaffa G, Christopher AN, et al. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. The Journal of Urology. 2014;191(1): 164–168. https://doi.org/10.1016/j.juro.2013.07.034.
Ortaç M, Çevik G, Akdere H, Ermeç B, Kadıoğlu A. Anatomic and Functional Outcome Following Distal Shunt and Tunneling for Treatment İschemic Priapism: A Single-Center Experience. The Journal of Sexual Medicine. 2019;16(8): 1290–1296. https://doi.org/10.1016/j.jsxm.2019.05.011.
Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. The Journal of Sexual Medicine. 2008;5(5): 1244–1250. https://doi.org/10.1111/j.1743-6109.2008.00770.x.
Kulmala RV, Lehtonen TA, Lindholm TS, Tammela TL. Permanent open shunt as a reason for impotence or reduced potency after surgical treatment of priapism in 26 patients. International Journal of Impotence Research. 1995;7(3): 175–180.
Fuchs JS, Shakir N, McKibben MJ, Mathur S, Teeple S, Scott JM, et al. Penoscrotal Decompression-Promising New Treatment Paradigm for Refractory Ischemic Priapism. The Journal of Sexual Medicine. 2018;15(5): 797–802. https://doi.org/10.1016/j.jsxm.2018.02.010.
Winter CC. Priapism cured by creation of fistulas between glans penis and corpora cavernosa. The Journal of Urology. 1978;119(2): 227–228. https://doi.org/10.1016/s0022-5347(17)57440-6.
Segal RL, Readal N, Pierorazio PM, Burnett AL, Bivalacqua TJ. Corporal Burnett ‘Snake’ surgical maneuver for the treatment of ischemic priapism: long-term followup. The Journal of Urology. 2013;189(3): 1025–1029. https://doi.org/10.1016/j.juro.2012.08.245.
Wilson SK, Zumbe J, Henry GD, Salem EA, Delk JR, Cleves MA. Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology. 2007;70(2): 337–340. https://doi.org/10.1016/j.urology.2007.03.058.
Wilson SK. Reimplantation of inflatable penile prosthesis into scarred corporeal bodies. International Journal of Impotence Research. 2003;15 Suppl 5: S125-128. https://doi.org/10.1038/sj.ijir.3901086.
Bozkurt İH, Yonguç T, Aydoğdu Ö, Değirmenci T, Arslan M, Minareci S. Use of a microdebrider for corporeal excavation and penile prosthesis implantation in men with severely fibrosed corpora cavernosa: a new minimal invasive surgical technique. Turkish Journal of Urology. 2015;41(3): 119–124. https://doi.org/10.5152/tud.2015.36539.
Tsambarlis PN, Chaus F, Levine LA. Successful Placement of Penile Prostheses in Men With Severe Corporal Fibrosis Following Vacuum Therapy Protocol. The Journal of Sexual Medicine. 2017;14(1): 44–46. https://doi.org/10.1016/j.jsxm.2016.11.304.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2025 Revista Mexicana de Urología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
